These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 22337078)

  • 41. Effects of tazarotene 0.1 % cream in the treatment of facial acne vulgaris: pooled results from two multicenter, double-blind, randomized, vehicle-controlled, parallel-group trials.
    Shalita AR; Berson DS; Thiboutot DM; Leyden JJ; Parizadeh D; Sefton J; Walker PS; Gibson JR;
    Clin Ther; 2004 Nov; 26(11):1865-73. PubMed ID: 15639698
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Status report from the American Acne & Rosacea Society on medical management of acne in adult women, part 2: topical therapies.
    Del Rosso JQ; Harper JC; Graber EM; Thiboutot D; Silverberg NB; Eichenfield LF
    Cutis; 2015 Nov; 96(5):321-5. PubMed ID: 26682555
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Photodynamic therapy of acne vulgaris using 5-aminolevulinic acid 0.5% liposomal spray and intense pulsed light in combination with topical keratolytic agents.
    de Leeuw J; van der Beek N; Bjerring P; Neumann HA
    J Eur Acad Dermatol Venereol; 2010 Apr; 24(4):460-9. PubMed ID: 19796088
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Trends in the treatment of acne vulgaris: are measures being taken to avoid antimicrobial resistance?
    Kinney MA; Yentzer BA; Fleischer AB; Feldman SR
    J Drugs Dermatol; 2010 May; 9(5):519-24. PubMed ID: 20480795
    [TBL] [Abstract][Full Text] [Related]  

  • 45. New and emerging treatments in dermatology: acne.
    Katsambas A; Dessinioti C
    Dermatol Ther; 2008; 21(2):86-95. PubMed ID: 18394082
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Is topical dapsone safe in glucose-6-phosphate dehydrogenase-deficient and sulfonamide-allergic patients?
    Webster GF
    J Drugs Dermatol; 2010 May; 9(5):532-6. PubMed ID: 20480797
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Effects of skin care and makeup under instructions from dermatologists on the quality of life of female patients with acne vulgaris.
    Matsuoka Y; Yoneda K; Sadahira C; Katsuura J; Moriue T; Kubota Y
    J Dermatol; 2006 Nov; 33(11):745-52. PubMed ID: 17073988
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Why are dermatologists still talking about acne? Because so many people have it... and we are always seeking better ways to manage it.
    Del Rosso JQ
    J Drugs Dermatol; 2011 Jun; 10(6):575-7. PubMed ID: 21637895
    [No Abstract]   [Full Text] [Related]  

  • 49. Combination of azelaic acid 5% and clindamycin 2% for the treatment of acne vulgaris.
    Pazoki-Toroudi H; Nilforoushzadeh MA; Ajami M; Jaffary F; Aboutaleb N; Nassiri-Kashani M; Firooz A
    Cutan Ocul Toxicol; 2011 Dec; 30(4):286-91. PubMed ID: 21612319
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Versatility of azelaic acid 15% gel in treatment of inflammatory acne vulgaris.
    Thiboutot D
    J Drugs Dermatol; 2008 Jan; 7(1):13-6. PubMed ID: 18246693
    [TBL] [Abstract][Full Text] [Related]  

  • 51. A comparative review of the efficacy and tolerability of retinoid-containing combination regimens for the treatment of acne vulgaris.
    Campbell JL
    J Drugs Dermatol; 2007 Jun; 6(6):625-9. PubMed ID: 17668528
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Clinical trials in dermatology. Evaluation of the tolerability and efficacy of a topical anti-acne].
    Verschoore M; Poncet M; Schaefer H; Revuz J; De Prost Y; Guillaume JC; Ortonne JP; Czernielewski J
    Therapie; 1991; 46(3):189-91. PubMed ID: 1838841
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Sodium L-ascorbyl-2-phosphate 5% lotion for the treatment of acne vulgaris: a randomized, double-blind, controlled trial.
    Woolery-Lloyd H; Baumann L; Ikeno H
    J Cosmet Dermatol; 2010 Mar; 9(1):22-7. PubMed ID: 20367669
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Azelaic acid therapy for acne.
    Mackrides PS; Shaughnessy AF
    Am Fam Physician; 1996 Dec; 54(8):2457-9. PubMed ID: 8961845
    [TBL] [Abstract][Full Text] [Related]  

  • 55. A practical approach for the use of oral isotretinoin for infantile acne.
    Barnes CJ; Eichenfield LF; Lee J; Cunningham BB
    Pediatr Dermatol; 2005; 22(2):166-9. PubMed ID: 15804310
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Pharmacotherapy of acne.
    Degitz K; Ochsendorf F
    Expert Opin Pharmacother; 2008 Apr; 9(6):955-71. PubMed ID: 18377339
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Acne vulgaris: pathogenesis and therapeutic approach.
    Federman DG; Kirsner RS
    Am J Manag Care; 2000 Jan; 6(1):78-87; quiz 88-9. PubMed ID: 11009749
    [TBL] [Abstract][Full Text] [Related]  

  • 58. A review on the treatment of acne vulgaris.
    Layton AM
    Int J Clin Pract; 2006 Jan; 60(1):64-72. PubMed ID: 16409430
    [TBL] [Abstract][Full Text] [Related]  

  • 59. The pulsed-dye laser as an adjuvant treatment modality in acne vulgaris: a randomized controlled single-blinded trial.
    Karsai S; Schmitt L; Raulin C
    Br J Dermatol; 2010 Aug; 163(2):395-401. PubMed ID: 20394631
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Isotretinoin dosing: past, present, and future trends.
    Hirsch RJ; Shalita AR
    Semin Cutan Med Surg; 2001 Sep; 20(3):162-5. PubMed ID: 11594671
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.